# Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sintilimab-plus-platinum-and-gemcitabine-as-first-line-treatment-for-advanced-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Caicun Zhou,Caicun Zhou,Lin Wu,Yun Fan,Zhehai Wang,Lianke Liu,Gongyan Chen,Li Zhang,Dingzhi Huang,Shundong Cang,Zhixiong Yang,Jianying Zhou,Chengzhi Zhou,Chengzhi Zhou,Baolan Li,Juan Li,Min Fan,Jiuwei Cui,Yuping Li,Hui Zhao,Jian Fang,Jianxin Xue,Chengping Hu,Ping Sun,Yingying Du,Hui Zhou,Shuyan Wang,Wen Zhang |
| Citations | 322 |
| DOI | 10.1016/j.jtho.2021.04.011 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086421021286/pdf |
| OpenAlex ID | https://openalex.org/W3165007730 |
| PMID | 34048947 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Lin Wu](https://scholariq.org/researchers/lin-wu/)
- [Yuping Li](https://scholariq.org/researchers/yuping-li/)
- [Shundong Cang](https://scholariq.org/researchers/shundong-cang/)
- [Jianxin Xue](https://scholariq.org/researchers/jianxin-xue/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.